Burkitt's lymphoma overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
Burkitt's lymphoma was first described by [[Denis Parsons Burkitt]], a [[surgeon]], in 1958 while working in equatorial Africa. | Burkitt's lymphoma was first described by [[Denis Parsons Burkitt]], a [[surgeon]], in 1958 while working in equatorial Africa. | ||
==Classification== | ==Classification== | ||
Burkitt's lymphoma may be classified according to WHO classification into 3 clinical variants: endemic Burkitt's lymphoma, sporadic Burkitt's lymphoma, and immunodeficiency-associated Burkitt's lymphoma. | Burkitt's lymphoma may be classified according to WHO classification into 3 clinical variants: endemic Burkitt's lymphoma, sporadic Burkitt's lymphoma, and immunodeficiency-associated Burkitt's lymphoma. | ||
==Pathophysiology== | ==Pathophysiology== | ||
| Line 19: | Line 18: | ||
There are no established causes for Burkitt's lymphoma. | There are no established causes for Burkitt's lymphoma. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Burkitt's lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with Burkitt's lymphoma than females. Burkitt's lymphoma usually affects individuals of the African race. | Burkitt's lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with Burkitt's lymphoma than females. Burkitt's lymphoma usually affects individuals of the African race. | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of Burkitt's lymphoma may be [[HIV]]/[[AIDS]] and post-transplant immunosuppression. | Common risk factors in the development of Burkitt's lymphoma may be [[HIV]]/[[AIDS]] and post-transplant immunosuppression. | ||
==Screening== | ==Screening== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Burkitt's lymphoma. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Burkitt's lymphoma. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis varies with the age, children have the most favorable prognosis. Burkitt's lymphoma in children is associated with a 5 year survival rate of 90%. The presence of metastasis in [[bone marrow]] or [[CNS]] is associated with a particularly poor prognosis among patients with Burkitt's lymphoma. | |||
==Diagnosis== | |||
===Staging=== | |||
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement. | |||
===Laboratory Findings=== | |||
Laboratory tests for Burkitt's lymphoma include [[complete blood count]] (CBC), blood chemistry studies, immuno histochemistry, [[HIV]] blood test, flow cytometric analysis, and [[cytogenetics]]. | |||
===Chest X ray=== | |||
Presence of [[Pulmonary nodule|nodules]] and [[pleural effusion]] on chest x ray may be suggestive of Burkitt's lymphoma. | |||
===CT=== | |||
Chest, abdomen, and pelvis [[CT]] scan may be helpful in the diagnosis of Burkitt's lymphoma. | |||
===MRI=== | |||
[[MRI]] scan may be helpful in the diagnosis of Burkitt's lymphoma. | |||
===Biopsy=== | |||
[[Lymph node]] or extra nodal tissue [[biopsy]] is diagnostic of Burkitt's lymphoma. | |||
===Other Imaging Studies=== | |||
[[PET]] scan may be helpful in the diagnosis of Burkitt's lymphoma. | |||
===Other diagnostic studies=== | |||
Other diagnostic studies for the diagnosis of Burkitt's lymphoma include [[bone marrow biopsy]] and spinal fluid examination. | |||
==Treatment== | |||
===Medical Therapy=== | |||
The predominant therapy for Burkitt's lymphoma is chemotherapy. Adjunctive [[immunotherapy]] and [[stem cell transplantation]] may be required. | |||
===Surgery=== | |||
Surgical intervention is not recommended for the management of Burkitt's lymphoma. | |||
==References== | ==References== | ||
Revision as of 13:52, 2 October 2015
|
Burkitt's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Burkitt's lymphoma overview On the Web |
|
American Roentgen Ray Society Images of Burkitt's lymphoma overview |
|
Risk calculators and risk factors for Burkitt's lymphoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Burkitt's lymphoma (or "Burkitt's tumor", or "Malignant lymphoma, Burkitt's type") is a cancer of the lymphatic system (in particular, B lymphocytes). It is associated with the Epstein-Barr virus, also the cause of mononucleosis as well as other cancers. It is named after Denis Parsons Burkitt, a surgeon who first described the disease in 1956 while working in equatorial Africa.
Children affected with the disease often also had chronic malaria which is believed to have reduced resistance to the Epstein-Barr virus and allowed it to take hold. This is known as classical African or endemic Burkitt's lymphoma. Disease characteristics include large tumors in the facial or abdominal regions.
The sporadic type of Burkitt's lymphoma (also known as "non-African") is another form of non-Hodgkin lymphoma found outside of Africa in which cancer cells have a similar appearance to the cancer cells of classical African or endemic Burkitt's lymphoma. Again it is believed that impaired immunity provides an opening for development of the Epstein-Barr virus. Examination of chromosomes from these tumor cells often shows translocation of the myc and Ig genes (t: 8;14).
Historical Perspective
Burkitt's lymphoma was first described by Denis Parsons Burkitt, a surgeon, in 1958 while working in equatorial Africa.
Classification
Burkitt's lymphoma may be classified according to WHO classification into 3 clinical variants: endemic Burkitt's lymphoma, sporadic Burkitt's lymphoma, and immunodeficiency-associated Burkitt's lymphoma.
Pathophysiology
Gene involved in the pathogenesis of Burkitt's lymphoma includes c-myc. On gross pathology, ulceration and discharge are characteristic findings of Burkitt's lymphoma. On microscopic histopathological analysis, "starry sky" appearance is characteristic finding of Burkitt's lymphoma.
Causes
There are no established causes for Burkitt's lymphoma.
Epidemiology and Demographics
Burkitt's lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with Burkitt's lymphoma than females. Burkitt's lymphoma usually affects individuals of the African race.
Risk Factors
Common risk factors in the development of Burkitt's lymphoma may be HIV/AIDS and post-transplant immunosuppression.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Burkitt's lymphoma.
Prognosis
The prognosis varies with the age, children have the most favorable prognosis. Burkitt's lymphoma in children is associated with a 5 year survival rate of 90%. The presence of metastasis in bone marrow or CNS is associated with a particularly poor prognosis among patients with Burkitt's lymphoma.
Diagnosis
Staging
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement.
Laboratory Findings
Laboratory tests for Burkitt's lymphoma include complete blood count (CBC), blood chemistry studies, immuno histochemistry, HIV blood test, flow cytometric analysis, and cytogenetics.
Chest X ray
Presence of nodules and pleural effusion on chest x ray may be suggestive of Burkitt's lymphoma.
CT
Chest, abdomen, and pelvis CT scan may be helpful in the diagnosis of Burkitt's lymphoma.
MRI
MRI scan may be helpful in the diagnosis of Burkitt's lymphoma.
Biopsy
Lymph node or extra nodal tissue biopsy is diagnostic of Burkitt's lymphoma.
Other Imaging Studies
PET scan may be helpful in the diagnosis of Burkitt's lymphoma.
Other diagnostic studies
Other diagnostic studies for the diagnosis of Burkitt's lymphoma include bone marrow biopsy and spinal fluid examination.
Treatment
Medical Therapy
The predominant therapy for Burkitt's lymphoma is chemotherapy. Adjunctive immunotherapy and stem cell transplantation may be required.
Surgery
Surgical intervention is not recommended for the management of Burkitt's lymphoma.